Publications by authors named "Shinpei Ushiyama"

Claim this Profile
A
ASO Visual Abstract: Is Surgery Necessary for Stage IVB Gastric Cancer Showing Clinical Complete Response to Chemotherapy or Systemic Cancer Therapy?
Takumi Habu, Shinpei Ushiyama, Izuma Nakayama, Masahiro Yura, Mitsumasa Yoshida

Ann Surg Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable Complete Response and Potential Cure With Systemic Chemotherapy in Metastatic Gastric Cancer: A Case Series of Patients.
Shinpei Ushiyama, Takumi Habu, Izuma Nakayama, Mitsumasa Yoshida, Naoya Sakamoto

JCO Oncol Pract· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Surgery Necessary for Stage IVB Gastric Cancer Showing Clinical Complete Response to Chemotherapy or Systemic Cancer Therapy?
Takumi Habu, Shinpei Ushiyama, Izuma Nakayama, Masahiro Yura, Mitsumasa Yoshida

Ann Surg Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of claudin 18.2 expression on treatment outcomes of first-line immunochemotherapy in patients with HER2-negative, proficient MMR, PD-L1 CPS ⩾1 metastatic gastric/gastroesophageal junction cancer.
Fei Zhang, Izuma Nakayama, Naoya Sakamoto, Dai Okemoto, Amane Jubashi, Shinpei Ushiyama

Ther Adv Med Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Indicators of Preoperative Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Efficacy in Locally Advanced Gastroesophageal and Gastric Cancer: Integrating Biomarker Analysis and Clinicopathological Factors.
Amane Jubashi, Izuma Nakayama, Naoya Sakamoto, Shogo Takei, Yuki Matsubara, Shinpei Ushiyama

JCO Precis Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive factors for the efficacy and safety of trastuzumab deruxtecan in HER2-positive gastric or gastroesophageal junction cancer.
Amane Jubashi, Izuma Nakayama, Shigehiro Koganemaru, Naoya Sakamoto, Shioto Oda, Shinpei Ushiyama

Gastric Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis